| Title |
The cost of schizophrenia in Japan
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, May 2013
|
| DOI | 10.2147/ndt.s41632 |
| Pubmed ID | |
| Authors |
Mitsuhiro Sado, Ataru Inagaki, Akihiro Koreki, Knapp, Lee Andrew Kissane, Mimura, Kimio Yoshimura |
| Abstract |
Schizophrenia is a disorder that produces considerable burdens due to its often relapsing/remitting or chronic longitudinal course. This burden is felt not only by patients themselves, but also by their families and health care systems. Although the societal burden caused by this disorder has been evaluated in several countries, the magnitude of the societal cost of schizophrenia in Japan has never been estimated. The aim of this study is to clarify the societal burden of schizophrenia by estimating the cost of schizophrenia in Japan in 2008. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 68 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 26% |
| Student > Bachelor | 10 | 15% |
| Student > Master | 7 | 10% |
| Student > Ph. D. Student | 5 | 7% |
| Student > Doctoral Student | 3 | 4% |
| Other | 8 | 12% |
| Unknown | 17 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 16% |
| Economics, Econometrics and Finance | 9 | 13% |
| Psychology | 9 | 13% |
| Agricultural and Biological Sciences | 5 | 7% |
| Nursing and Health Professions | 4 | 6% |
| Other | 7 | 10% |
| Unknown | 23 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2013.
All research outputs
#15,655,167
of 24,797,973 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,567
of 3,109 outputs
Outputs of similar age
#113,672
of 196,801 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#27
of 53 outputs
Altmetric has tracked 24,797,973 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,109 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,801 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.